Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | VCP | P55072 | 3/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.40 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | USP1 | O94782 | 1/20 | 0.37 |
| ▸ | WDR48 | Q8TAF3 | 1/20 | 0.37 |
| ▸ | CLK2 | P49760 | 1/20 | 0.37 |
| ▸ | CLK3 | P49761 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4568286 | 0.85 | CYP19A1 (0.53) | CYP19A1CYP2A6VCPNPY5RHPGDS | |
| SCHEMBL4568300 | 0.84 | NPC1 (0.47) | CYP19A1VCPNPY5RKMT2A | |
| SCHEMBL1606072 | 0.84 | CYP19A1 (0.65) | CYP19A1CYP2A6NPY5RKMT2ACLK2 | |
| SCHEMBL4568294 | 0.79 | CYP19A1 (0.58) | CYP19A1CYP2A6VCPNPY5RKMT2A | |
| SCHEMBL4568283 | 0.79 | CYP19A1 (0.58) | CYP19A1CYP2A6NPY5RKMT2ACLK2 | |
| SCHEMBL4568281 | 0.78 | CYP19A1 (0.61) | CYP19A1CYP2A6VCPNPY5RHPGDS | |
| SCHEMBL4568280 | 0.77 | CYP19A1 (0.56) | CYP19A1CYP2A6NPY5RKMT2ACYP11B1 | |
| SCHEMBL4568273 | 0.76 | CYP19A1 (0.58) | CYP19A1CYP2A6NPY5RKMT2ACLK2 | |
| SCHEMBL4568302 | 0.74 | CDK5 (0.36) | CYP2A6NPY5RKMT2A | |
| SCHEMBL7946248 | 0.74 | CYP19A1 (0.68) | CYP19A1CYP2A6NPY5RKMT2ACLK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2474530-B1 | INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KISSEI PHARMACEUTICAL (JP) | 2014-09-03 | — | — | EP | disclosed |
| US-20120122931-A1 | INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| US-20120122931-A1 | INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122931-A1 | INDOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | PTGER1, CYSLTR1, LTB4R | CYP19A1 1262/4885CYP2A6 1025/4885VCP 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.